Psychosocial distress in cancer patients undergoing radiotherapy: a prospective national cohort of 1042 patients in Germany.


Journal

Journal of cancer research and clinical oncology
ISSN: 1432-1335
Titre abrégé: J Cancer Res Clin Oncol
Pays: Germany
ID NLM: 7902060

Informations de publication

Date de publication:
Sep 2023
Historique:
received: 29 03 2023
accepted: 02 05 2023
medline: 31 7 2023
pubmed: 11 5 2023
entrez: 10 5 2023
Statut: ppublish

Résumé

Psychosocial distress is common among cancer patients in general, but those undergoing radiotherapy may face specific challenges. Therefore, we investigated the prevalence and risk factors for distress in a large national cohort. We performed a secondary analysis of a multicenter prospective cross-sectional study which surveyed cancer patients at the end of a course of radiotherapy using a patient-reported questionnaire. Distress was measured with the distress thermometer (DT), using a cut-off of ≥ 5 points for clinically significant distress. Univariate analyses and multivariate multiple regression were used to assess associations of distress with patient characteristics. A two-sided p-value < 0.05 was considered statistically significant. Out of 2341 potentially eligible patients, 1075 participated in the study, of which 1042 completed the DT. The median age was 65 years and 49% (511/1042) of patients were female. The mean DT score was 5.2 (SD = 2.6). Clinically significant distress was reported by 63% (766/1042) of patients. Of the patient characteristics that were significantly associated with distress in the univariate analysis, a lower level of education, a higher degree of income loss, lower global quality of life, and a longer duration of radiotherapy in days remained significantly associated with higher distress in the multivariate analysis. Yet effect sizes of these associations were small. Nearly two in three cancer patients undergoing radiotherapy reported clinically significant distress in a large multicenter cohort. While screening and interventions to reduce distress should be maintained and promoted, the identified risk factors may help to raise awareness in clinical practice. DRKS: German Clinical Trial Registry identifier: DRKS00028784.

Identifiants

pubmed: 37165119
doi: 10.1007/s00432-023-04837-5
pii: 10.1007/s00432-023-04837-5
pmc: PMC10374761
doi:

Banques de données

DRKS
['DRKS00028784']

Types de publication

Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

9017-9024

Informations de copyright

© 2023. The Author(s).

Références

Gynecol Oncol. 2022 Oct;167(1):42-50
pubmed: 36064679
Radiother Oncol. 2023 Jun;183:109604
pubmed: 36889598
Lung Cancer. 2019 Apr;130:101-107
pubmed: 30885329
J Natl Cancer Inst. 1993 Mar 3;85(5):365-76
pubmed: 8433390
Cochrane Database Syst Rev. 2019 Sep 03;9:CD011462
pubmed: 31476800
Adv Radiat Oncol. 2018 Nov 14;4(2):354-361
pubmed: 31011681
Psychooncology. 2018 Jan;27(1):75-82
pubmed: 28568377
J Clin Epidemiol. 2001 Apr;54(4):343-9
pubmed: 11297884
Radiother Oncol. 2011 Aug;100(2):299-303
pubmed: 21316782
J Natl Compr Canc Netw. 2019 Oct 1;17(10):1229-1249
pubmed: 31590149
J Psychosom Res. 2016 Aug;87:14-21
pubmed: 27411747
J Oncol Pract. 2015 Jul;11(4):298-302
pubmed: 26188046
J Cancer Res Clin Oncol. 2023 Mar;149(3):1343-1354
pubmed: 36166092
Support Care Cancer. 2019 Aug;27(8):2799-2807
pubmed: 30539312
Anticancer Res. 2022 Nov;42(11):5561-5566
pubmed: 36288853
Adv Radiat Oncol. 2017 Mar 20;2(2):211-219
pubmed: 28740934
J Clin Oncol. 2018 Mar 10;36(8):780-788
pubmed: 29369731
Ann Oncol. 2016 Sep;27(9):1754-60
pubmed: 27287209
PLoS Med. 2007 Oct 16;4(10):e296
pubmed: 17941714
Epidemiol Psychiatr Sci. 2020 Jan 09;29:e85
pubmed: 31915097
Strahlenther Onkol. 2021 Apr;197(4):269-280
pubmed: 33507331
J Cancer Res Clin Oncol. 2019 Nov;145(11):2845-2854
pubmed: 31506739
J Cancer Res Clin Oncol. 2023 Aug;149(9):5655-5663
pubmed: 36527483
Br J Cancer. 2018 Jun;118(12):1549-1558
pubmed: 29855611
Acta Oncol. 2017 Dec;56(12):1720-1727
pubmed: 28893119
J Psychosoc Oncol. 2019 Jan-Feb;37(1):5-21
pubmed: 30592249
Prostate Cancer Prostatic Dis. 2021 Sep;24(3):674-687
pubmed: 33750905
Mol Oncol. 2020 Jul;14(7):1461-1469
pubmed: 32293084
Laryngoscope. 2021 Sep;131(9):2023-2029
pubmed: 33720420
JAMA. 2013 Feb 27;309(8):814-22
pubmed: 23443445
Strahlenther Onkol. 2022 Dec;198(12):1053-1061
pubmed: 35467099
BMC Cancer. 2014 Sep 30;14:731
pubmed: 25266325

Auteurs

Alexander Fabian (A)

Department of Radiation Oncology, University Hospital Schleswig-Holstein, Arnold-Heller-Str. 3, 24105, Kiel, Germany. alexander.fabian@uksh.de.

Alexander Rühle (A)

Department of Radiation Oncology, Medical Center, Faculty of Medicine, University of Freiburg, 79106, Freiburg, Germany.
Department of Radiotherapy and Radiation Oncology, University Hospital Leipzig, 04103, Leipzig, Germany.

Justus Domschikowski (J)

Department of Radiation Oncology, University Hospital Schleswig-Holstein, Arnold-Heller-Str. 3, 24105, Kiel, Germany.

Maike Trommer (M)

Department of Radiation Oncology, Cyberknife and Radiotherapy, Faculty of Medicine and University Hospital Cologne, 50937, Cologne, Germany.
Center for Molecular Medicine Cologne, University of Cologne, 50931, Cologne, Germany.

Simone Wegen (S)

Department of Radiation Oncology, Cyberknife and Radiotherapy, Faculty of Medicine and University Hospital Cologne, 50937, Cologne, Germany.

Jan-Niklas Becker (JN)

Department of Radiotherapy and Special Oncology, Medical School Hannover, 30625, Hannover, Germany.

Georg Wurschi (G)

Department of Radiotherapy and Radiation Oncology, Jena University Hospital, 07740, Jena, Germany.

Simon Boeke (S)

Department of Radiation Oncology, University Hospital Tübingen, 72076, Tübingen, Germany.

Mathias Sonnhoff (M)

Center for Radiotherapy and Radiation Oncology, 28239, Bremen, Germany.

Christoph A Fink (CA)

Department of Radiation Oncology, University Hospital Heidelberg, 69120, Heidelberg, Germany.

Lukas Käsmann (L)

Department of Radiation Oncology, University Hospital, LMU Munich, 81377, Munich, Germany.
Comprehensive Pneumology Center Munich (CPC-M), Member of the German Center for Lung Research (DZL), 81377, Munich, Germany.
German Cancer Consortium (DKTK), Partner Site Munich, 81377, Munich, Germany.

Melanie Schneider (M)

Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, 01307, Dresden, Germany.

Elodie Bockelmann (E)

Department of Radiotherapy and Radiation Oncology, University Hospital Hamburg-Eppendorf, 20251, Hamburg, Germany.

Martin Treppner (M)

Institute of Medical Biometry and Statistics, University Hospital Freiburg, 79106, Freiburg, Germany.

Anja Mehnert-Theuerkauf (A)

Department of Medical Psychology and Medical Sociology, University Medical Center Leipzig, 04103, Leipzig, Germany.

David Krug (D)

Department of Radiation Oncology, University Hospital Schleswig-Holstein, Arnold-Heller-Str. 3, 24105, Kiel, Germany.

Nils H Nicolay (NH)

Department of Radiotherapy and Radiation Oncology, University Hospital Leipzig, 04103, Leipzig, Germany.
Cancer Center Central Germany, Partner Site Leipzig, 04103, Leipzig, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH